Abi Bautista-Alejandre, Assistant Editor

Adolescent dogs aren’t just 'difficult,' their brains are under construction. In this video, Christopher Pachel, DVM, DACVB, CABC, explains the neuroscience behind the teenage phase.

Veterinarians gain a new FDA-approved generic dewormer, Defendazole, for the treatment and control of various worms in cattle and goats.

Training teenage dogs isn’t the same as training puppies or adults—but why? Christopher Pachel, DVM, DACVB, CABC (IAABC), breaks it down.

The latest updates relating to animal care establishments and platforms.

“Sometimes the biggest reason you feel exhausted at the end of the day has nothing to do with how much you're doing,” Jennifer Edwards, DVM, ACC, CPC, ELI-MP, said in this episode of The Resilient Vet: Mind and Body Strategies for Success.

The approval broadens the drug's label, which already covers the management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.

Brennen McKenzie, MA, MSc, VMD, emphasizes understanding the biology of aging, delivering high-quality medical care, and maintaining effective client communication as key factors in helping dogs live longer, healthier lives.

Royal Canin unveils a new diet for cats with diabetes and home care kits at VMX 2026.

"I think nutrition is important, but I think it's often oversimplified," says Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal.

In this guide to the canine adolescent years, Christopher Pachel, DVM, DACVB, CABC (IAABC), breaks down this critical phase—from hormones to the prefrontal cortex—based on his 2026 VMX session in Orlando, Florida.

Antech Diagnostics unveils RapidRead Dental for Feline and symmetric dimethylarginine testing on its Element i+ platform.

Verdinexor tablets (Laverdia; Anivive Lifesciences) are the first oral treatment for managing lymphoma in dogs.

The cofounder of a biotech developing 3D-printing compounding technology company discusses the company's official entrance into the veterinary space, in this Q&A.

Supporting clients in keeping pets lean and up to date on vaccines and parasite prevention are simple steps veterinarians can take to help pets live longer, healthier lives, explains Brennen McKenzie, MA, MSc, VMD.

In this video, Christopher Pachel, DVM, DACVB, CABC (IAABC) emphasizes the importance finding the right solution for each patient.

A surge in influenza cases this past season coincides with acetaminophen appearing on the Pet Poison Helpline’s 2025 list of the most commonly reported toxins for cats and dogs.

Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, a biotechnology company focusing on extending the healthy lifespan of dogs, shares medications the company is developing.

Two of the new laws give shelters more veterinary flexibility.

The product first launched in Europe in 2013.

Christopher Pachel, DVM, DACVB, CABC, explains how veterinarians can tailor medication plans for dogs with separation anxiety by matching maintenance or situational drugs to each patient’s schedule and needs.

New leadership moves, recognition, and achievement.

Thinking about age as a modifiable risk factor is reshaping how veterinarians approach care for aging dogs.

Brennen McKenzie, MA, MSc, VMD, director of veterinary medicine at Loyal, explains how energy metabolism changes as dogs age, and the health issues these changes can lead to.

Inflammatory bowel disease (IBD) may progress to feline small cell gastrointestinal (GI) lymphoma, researchers say. Texas A&M University is testing a new treatment option for the cancer.

The latest updates relating to animal care establishments and platforms.

Learn how to increase resilience in your career through intentional physical and emotional warm-ups before the start of a shift.

Christopher Pachel, DVM, DACVB, CABC (IAABC), discusses whether a separation anxiety case warrants medication in this interview with dvm360.

The latest products and innovative technology in veterinary medicine.

Zygolide by Dechra offers a generic, bioequivalent option for managing pituitary pars intermedia dysfunction in horses.

New leadership moves, recognition, and achievement.